Robert Hoffman

Robert Hoffman is a declared insider at 3 companies; the most frequent names are Heron Therapeutics, Inc. /DE/, CombiMatrix Corp and Mabvax Therapeutics Holdings, Inc. We count 10 filings; the first trade dates from 4 April 2016 and the latest from 2 July 2018.

The open-market side counts 1 purchase for €14k alongside 2 sales for €984k. The net balance comes to €970k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 option exercises. 2018 to date brings no purchases and 2 sales.

Most recently, on 3 July 2018, the filings show a transaction worth €8,141 in Heron Therapeutics, Inc. /DE/. The clock since the last published purchase (10 May 2016) now reads 3,818 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.